Teleflex Incorporated 10-K Summary: Fiscal Year Ended December 31, 2000
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2000, for Teleflex Incorporated, a Delaware corporation. The Company operates as a manufacturer of precision mechanical and electrical controls, fluid transfer products, and medical devices. Its business is organized into three segments: Commercial (automotive, marine, industrial), Medical (hospital supply, surgical devices), and Aerospace (cargo systems, turbine engine components). As of December 31, 2000, the Company employed approximately 16,600 people and operated roughly 120 facilities globally.
Key Financial Metrics
The filing text incorporates the Consolidated Financial Statements and Selected Financial Data by reference to the 2000 Annual Report to Shareholders; therefore, specific values for revenue, net income, cash flow, margins, debt, and liquidity are not explicitly stated in the provided text. However, the following financial data points are available:
- Market Capitalization: Approximately $1.42 billion (aggregate market value of voting stock held by non-affiliates as of February 1, 2001).
- Shares Outstanding: 38,448,912 Common Shares as of February 1, 2001.
- Allowance for Doubtful Accounts: Ended the year at $5,776,000, with additions of $2,460,000 charged to income and write-offs of $1,509,000.
- Order Backlog (Firm Orders):
- Aerospace Segment: $303 million (anticipated >50% filled in 2001).
- Commercial Segment: $139 million.
- Medical Segment: $28 million.
Material Changes and Segment Performance
The Company reported the following sales mix for 2000: Commercial (49%), Aerospace (28%), and Medical (23%). Significant operational changes and acquisitions included:
- Commercial Segment: Acquired a Tier I supplier of alternative fuel vehicle components in 2000. Agreed to acquire Morse Controls (adding $150 million in sales) in 2000, with the deal closing in February 2001.
- Medical Segment: Acquired Medical Marketing Group in 2000 to expand specialty catheter offerings in the U.S. homecare market.
- Aerospace Segment: Acquired Air Cargo Equipment Corporation in 2000 to complement cargo handling systems. Acquired Turbine Technology Services Corporation to expand coatings and repair services.
- Leadership Changes: Lennox K. Black replaced David S. Boyer as Chief Executive Officer on January 31, 2000. Jeffrey P. Black was elected President on December 8, 2000.
Outlook, Risks, and Contingencies
Outlook and Strategy: The Company continues to invest in the "New Venture Fund," directing 0.5% of sales into new product development. Management anticipates that more than half of the $303 million Aerospace backlog will be filled in 2001, while substantially all Medical and Commercial backlog will be filled in 2001.
Risks and Contingencies:
- Environmental: The Company is subject to various environmental laws and has been named a potentially responsible party at various sites by the EPA. Management does not expect environmental costs to be material to the consolidated financial position.
- Competition: The Company faces varying degrees of competition across all segments but relies on technical competence and engineering capabilities for its competitive position.
- Patents: The Company owns numerous patents but does not believe its business is materially dependent on patent protection.
Investor Verification Checklist
- Verify the specific revenue, net income, and cash flow figures in the "Selected Financial Data" and "Consolidated Financial Statements" of the 2000 Annual Report to Shareholders (incorporated by reference).
- Confirm the closing status and financial impact of the Morse Controls acquisition (agreed in 2000, closed Feb 2001).
- Review the "Liquidity, Market Risk and Capital Resources" section of the Annual Report for details on debt levels and liquidity not present in this text.
- Assess the impact of the leadership transition from David S. Boyer to Lennox K. Black on strategic direction.
- Monitor the execution of the $303 million Aerospace backlog and the integration of recent acquisitions in the Medical and Commercial segments.